Module 2: Common Technical Document Summaries
Module 2 provides overviews and summaries of Modules 3, 4, and 5. It includes the Quality Overall Summary, Nonclinical Overview, Clinical Overview, and detailed written/tabulated summaries.
Sections
Table of contents for the CTD
Brief introduction to the drug including pharmacological class and proposed indication
Quality overall summary covering drug substance and drug product (40-80 pages for NDA)
Nonclinical overview: integrated assessment of pharmacology, PK, and toxicology (~30 pages for NDA)
Clinical overview: benefit-risk analysis based on all clinical data (~30 pages for NDA)
Nonclinical written and tabulated summaries covering pharmacology, PK, and toxicology (100-150 pages for NDA)
Clinical summary: detailed summary of clinical pharmacology, efficacy, and safety (50-400 pages for NDA)
Related Sections
Module 1 contains documents that are specific to each region. It includes administrative information such as application forms, prescribing information, and labeling. This module is NOT part of the Common Technical Document (CTD) and varies by regulatory region.
Module 3 contains the Body of Data for drug substance (S) and drug product (P) quality information, including manufacturing, controls, characterization, and stability per ICH M4Q guidelines.
Module 4 contains nonclinical study reports organized per ICH M4S: pharmacology (primary, secondary, safety), pharmacokinetics (ADME), and toxicology (general, genetic, carcinogenicity, reproductive).
Module 5 contains clinical study reports organized per ICH M4E: biopharmaceutic studies, human PK/PD studies, efficacy and safety studies, post-marketing data, and case report forms.
Check your compliance against this section
Upload your study data and get instant gap analysis with specific regulatory citations.
Try Compliance Check